TCPL delivery system as a model for E+P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition

Biomedical Sciences Instrumentation

Volumn 39, Issue , 2003, Pages 529-534

  Cason, Zelma ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a   England, Barry ^a  

^a NONE

Author keywords

Drug Delivery; Ovarian Events; Ovariectomized Rats; Progesterone; Progestins; Reproductive Hormones

Indexed keywords

BIOASSAY; BLOOD; IMMUNOLOGY; PHYSIOLOGY;

HORMONE REPLACEMENT THERAPY (HRT);

HORMONES;

CALCIUM PHOSPHATE CERAMIC; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; LUTEINIZING HORMONE BLOOD LEVEL; MODEL; NONHUMAN; OVARIECTOMY; PAPANICOLAOU TEST; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; VAGINA EPITHELIUM;

EID: 0037261413     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Benghuzzi, HA and Bajpai, PK. Sustained Delivery of Difluoromethylomithine (DFMO) by means of Implantable Ceramic Devices. Journal of Investigative Surgery, 1988;1:63-170, 1988.
2. Benghuzzi, HA, England, BG, Bajpai, PK. and Giffin, BF. Successful Antidote of Multiple Lethal Infections Using Sustained Delivery of Difluoromethylomithine by Means of Ceramic Drug Delivery Devices. Journal of Clinical Materials, 1994;15:151-160.
3. Benghuzzi, HA. Cytopathological Evaluation of Capsular Tissue Surrounding TCPL Implants in Adult Rats. Biomed. Sci. Inst. (ISA). 1996, Paper #96-011, 1996;32:81-86.
4. Cason Z, Tucci M, England B, and Benghuzzi H: Pathophysiological Changes Associated with Sustained Delivery of Estrogen and Estrogen Plus Progesterone by TCPL Devices. Biomed. Science Instrumentation, (Paper #98-005 ISA), 1998;34:24-29.
5. Mohamed A, Benghuzzi H. Morphological investigation of the rat kidney after continuous administration of testosterone, dihydrotestosterone, or dehydroepiandrosterone using TCPL delivery devices. Biomed Sci Instrum. 2000;36:361-6.
6. Byrd K, Benghuzzi H. The role of density on the release profiles of hydrophobic and hydrophilic compounds from TCPL delivery systems. Biomed Sci Instrum. 2000;36:165-70
7. Butler K, Benghuzzi H, Puckett A. Cytological evaluation of the tissue-implant reaction associated with S/C and I/P implantation of ALCAP and HA bioceramics in vivo. J. of Pathol: Res and Pract. 2001;197(1):29-39.
8. Hamed Benghuzzi And Barry England Biocompatibility Of Steroid-Ha Delivery System Using Adult Castrated Rams As A Model. Biomed Sci Instrum. 2001;37:275-280.
9. Carey, MP, Deterd CH, de Koning J, Helmerhorst F., de Kloet ER, (1995) The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinology. Vol 144(2):311-321
10. Tanaka, M. Kumai T Watanabe M. Matsumoto C. Hari M. Kobayashi S., (1994) Effects of hysterectomy on ovarian and related ovarian function in regular estrous cycle rats. Life Sciences. Vol 55(3):237-243.
11. Shirley, B. Reeder RL., (1976) Cyclic changes in the ampulla of the rat oviduct., J Experimental Zoology. Vol 276(2):164-173
12. Gambrell, RD (1985). Evidence supports estrogen-progesterone replacement therapy. Postgrad Med. 78:35-38.
13. Shaw, RW (1987). Adverse long-term administration of oral contraceptives: a review. Br. J. Obstet. Gynecol. 94:724-730.
14. Briggs, M. (1976). Biochemical effects of oral contraceptives. Adv. Steroid Biochem Pharmacol. 5:60-66.
15. Swerdloff, RS and Odell WD (1969). Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women. J Clin. Endocrinol. Metab. 29:157-163.